The added value of integrative medicine
Dr Gil Morgan from OncoAlert gives his oncology highlights from social media from day 1 of ASCO 2021.
Alerts cover trials such as OUTBACK, EXELOX, OlympiA, CodeBreaK 100 and EV201 Cohort 2.
Dr Morgan also talks about the steady increase in ASCO twitter impressions on the Onco community from 2016-2019, but explains there was an even more dramatic rise in 2020, the first year affected by the COVID-19 pandemic.
You can watch Dr Morgan's previous roundup here
Follow Dr Morgan on twitter: @OncoAlert
Follow ecancer on twitter: @ecancer
The added value of integrative medicine
Prostate cancer
Tele-mentoring: Impact of project ECHO
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Synthetic biology and precision medicine in blood and gynaecological cancers
OncoAlert Round Up for September 15-21, 2023
Choosing Wisely in radiology Tanzania
The use of IORT at Universitätsmedizin Mannheim hospital